Oral cavity antibacterial spray suitable for anaphylactic rhinitis patients

Abstract

The invention discloses an oral cavity antibacterial spray suitable for anaphylactic rhinitis patients. The main composition of the oral cavity antibacterial spray comprises 45% of a medicine ingredient which can kill pyogenic coccus and bacillus by weight, wherein the medicine ingredient is the extractive of viola yedoensis, notopterygium roots and galangal. The weight percentage of flavonoid glycosides in the main composition is less than or equal to 0.5%, the weight percentage of columbianetin in the main composition is less than or equal to 0.5%, and the weight percentage of methyl cinnamate in the main composition is less than or equal to 0.09 %. The oral cavity antibacterial spray suitable for anaphylactic rhinitis patients can be used for effectively killing nasosinusitis pathogenic bacteria in an oral cavity, and preventing the pathogenic bacteria in the oral cavity from infecting a nasal cavity.

Description

technical field [0001] The invention relates to an oral antibacterial spray suitable for patients with allergic rhinitis. Background technique [0002] Allergic rhinitis affects the patient's quality of life and aggravates the symptoms of respiratory tract infection. In severe cases, it may cause craniopharyngeal complications, resulting in changes in vision and even death due to aggravated infection. At the same time, allergic rhinitis is a disease that requires long-term treatment, and patients need long-term medication to control the disease. At present, the methods for treating allergic rhinitis mainly include oral administration of medicaments containing antibiotic ingredients and nasal spray (or drops) medication, both of which can play a role in killing pathogenic bacteria. [0003] However, the latest research has found that an important reason why allergic rhinitis can not be cured for a long time is that the pathogenic flora will multiply and grow in the oral cavi...

AI Technical Summary

Problems solved by technology

The oral cavity and the nasal cavity are a connected cavity, and pathogenic bacteria will spread to each other in the cavity. The existing treatment methods simply kill the pathogenic bacteria in the nasal cavity, but do not kill the pathogenic bacteria in the oral cavity. When the bacteria in the nasal cavity are killed, the pathogenic bacteria in the oral cavity will repeatedly infect the nasal cavity, resulting in persistent allergic rhinitis